In autoimmune prone murine strains, sequential engagement of the B cell antigen receptor (BCR) on the cell surface and toll-like receptors (TLRs) in late endosomes is necessary and sufficient for secretion of autoantibodies. However, ubiquitous nucleoprotein self-antigens fail to elicit productive TLR activation, and break self-tolerance in anergic DNA-reactive B cells. Immunogenicity is associated with the coordinated activation of a network of signaling pathways, including those leading to rapid intracellular calcium elevation, ERK, and JNK activation. Most anergic B cells manifest aberrant BCR-induced calcium responses and attenuated JNK activation (4, 5).Little is known about how immunogenic and tolerogenic ligands induce opposing cell fates. Initial investigations focused on differences in transcriptional programs (6). However, only a few transcription factors are consistently differentially regulated in anergic B cells (7). The apparent lack of correlation between transcriptional events and B cell anergy is not surprising, given the rapidity with which anergy can be reversed (5,(8)(9)(10).BCR signaling is not the only determinant of peripheral B cell activation. The recognition of pathogen-associated molecular patterns by toll-like receptors (TLRs) is important in the loss of B cell tolerance. Deficiency of myeloid differentiation primary response gene-88 (MyD88) in MRL/lpr mice abrogates autoantibody production (11), whereas deficiencies in TLR7 or TLR9 inhibit the production of antibodies against RNP and dsDNA, respectively (12). B cell activation through TLR7 and TLR9 is coupled to BCR recognition of ligand containing antigenic complexes (13-15). Presumably, this is because the BCR is the primary conduit into the late endosomes where these TLRs reside (16,17).Given the frequency of DNA-binding B cells in the peripheral repertoire, it might be expected that polyclonal anti-DNA antibody secretion would be a usual feature of the immune system (18, 19). However, in nonautoimmune prone strains, TLR ligands fail to overcome anergy. In anergic HEL-specific B cells, chronic activation of ERK inhibits CpG DNA-induced plasma cell differentiation in vitro (20). However, ERK activation is not a universal feature of B cell anergy (5). Therefore, other mechanism(s) must attenuate TLR activation in anergic B cells.
Results
Aberrant Endocytic Antigen Receptor Trafficking in Anergic 3H9/V 8Splenic B Cells. We first examined whether BCR endocytic trafficking was attenuated in peripheral anergic B cells from genetargeted mice expressing 3H9/V 8, a BCR specific for ssDNA and cardiolipin (21,22). Splenic B cells expressing either V 8, 3H9/V 8, or nontransgenic C57BL/6 WT B cells were stimulated with FITC-conjugated F(abЈ) 2 goat anti-mouse IgG/M (heavy and light chain) antibodies for 30 min at 37°C then fixed, counterstained with anti-Lamp-1 antibodies (ID4B), and visualized by confocal microscopy (23). As we show in Fig. 1A, BCR aggregation on WT splenic B cells induced internalization and endocytic targeting of aggregate...